[Changed equilibrium between the sympathetic-adenyl cyclase-cyclic AMP-PGE system and the cholinergic-guanyl cyclase-cyclic GMP-PGF2 alpha system as a pathogenetic mechanism of bronchial asthma].
D000262:Adenylyl Cyclases / Q000378:metabolism*; D001249:Asthma / Q000209:etiology* / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D006162:Guanylate Cyclase / Q000378:metabolism*; D006801:Humans; D011458:Prostaglandins E / Q000378:metabolism*; D011460:Prostaglandins F / Q000378:metabolism*; D011950:Receptors, Cholinergic / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000378:metabolism
D011458:Prostaglandins E; D011460:Prostaglandins F; D011950:Receptors, Cholinergic; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D006162:Guanylate Cyclase; D006152:Cyclic GMP
Alterato equilibrio tra: sistema simpatico-adeniciclasico-AMP ciclico-PGE e sistema colinergico-guanilciclasico-GMP ciclico-PGE2 alpha quale meccanismo patogenetico dell'asma bronchiale.